Cardiac Injury in Patients With Influenza

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

466 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-10-01

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study investigate the prevalence of elevated biomarkers of cardiac injury in patients with suspected influenza infection and the prognostic implication on the composite endpoint of death of any cause, hospitalization due to myocardial infarction, unstable angina, heart failure and stroke.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Timing of Influenza Vaccination in Patients With Heart Failure

NCT05507502

Heart Failure

UNKNOWN NA

Influenza Vaccination During Coronavirus Disease 2019 Outbreak After Acute Coronary Syndrome and Chronic Heart Failure

NCT05232292

Acute Coronary Syndrome Chronic Heart Failure

UNKNOWN PHASE4

Effect of Influenza Vaccination on Global Systemic Inflammatory Markers in Patients With Stable Coronary Artery Disease

NCT06508437

Coronary Artery Disease Inflammatory Response Atherosclerosis

COMPLETED PHASE4

INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure

NCT02787044

Heart Failure Myocardial Infarction

COMPLETED PHASE4

Study on the Effect of Influenza Vaccination After Heart Attack on Future Cardiovascular Prognosis

NCT02831608

Myocardial Infarction Influenza, Human Influenza Vaccines +2 more

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The relationship between influenza and cardiovascular events was described in an early study of influenza epidemics from 1915 to 1929 including the 1918-1920 pandemic. Retrospective studies have shown increased risk for acute myocardial infarction (AMI) during the first week following an infection with influenza.

Biochemical markers of cardiac injury such as high sensitive cardiac troponins may be increased during infection with influenza. Increased levels of cardiac troponins are associated with adverse outcome in many different populations.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Influenza, Human Myocardial Injury

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patients (\>18 years) presenting with influenza-like illness.
* Written informed consent.

Exclusion Criteria

* Inability to provide informed consent.
* Age \<18 years.
* Symptoms indicating an acute coronary syndrome, acute heart failure, rapid atrial fibrillation or acute stroke.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No